224 related articles for article (PubMed ID: 32171764)
21. Serum levels of carbohydrate antigen 125 in patients with chronic heart failure: relation to clinical severity, hemodynamic and Doppler echocardiographic abnormalities, and short-term prognosis.
D'Aloia A; Faggiano P; Aurigemma G; Bontempi L; Ruggeri G; Metra M; Nodari S; Dei Cas L
J Am Coll Cardiol; 2003 May; 41(10):1805-11. PubMed ID: 12767668
[TBL] [Abstract][Full Text] [Related]
22. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review.
Núñez J; de la Espriella R; Miñana G; Santas E; Llácer P; Núñez E; Palau P; Bodí V; Chorro FJ; Sanchis J; Lupón J; Bayés-Genís A
Eur J Heart Fail; 2021 Sep; 23(9):1445-1457. PubMed ID: 34241936
[TBL] [Abstract][Full Text] [Related]
23. Clinical and prognostic value of elevated CA125 levels in patients with coronary heart disease.
Rong X; Yunke Z; Guoping L; Zhenyue C
Herz; 2015 Jun; 40(4):690-4. PubMed ID: 24831034
[TBL] [Abstract][Full Text] [Related]
24. Carbohydrate antigen 125 predicts long-term mortality in African American patients with acute decompensated heart failure.
Mansour IN; Napan S; Tarek Alahdab M; Stamos TD
Congest Heart Fail; 2010; 16(1):15-20. PubMed ID: 20078623
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of the interaction between galectin-3 and antigen carbohydrate 125 in acute heart failure.
Núñez J; Rabinovich GA; Sandino J; Mainar L; Palau P; Santas E; Villanueva MP; Núñez E; Bodí V; Chorro FJ; Miñana G; Sanchis J
PLoS One; 2015; 10(4):e0122360. PubMed ID: 25875367
[TBL] [Abstract][Full Text] [Related]
26. The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study.
Markousis-Mavrogenis G; Tromp J; Ouwerkerk W; Devalaraja M; Anker SD; Cleland JG; Dickstein K; Filippatos GS; van der Harst P; Lang CC; Metra M; Ng LL; Ponikowski P; Samani NJ; Zannad F; Zwinderman AH; Hillege HL; van Veldhuisen DJ; Kakkar R; Voors AA; van der Meer P
Eur J Heart Fail; 2019 Aug; 21(8):965-973. PubMed ID: 31087601
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor 23 is related to profiles indicating volume overload, poor therapy optimization and prognosis in patients with new-onset and worsening heart failure.
Ter Maaten JM; Voors AA; Damman K; van der Meer P; Anker SD; Cleland JG; Dickstein K; Filippatos G; van der Harst P; Hillege HL; Lang CC; Metra M; Navis G; Ng L; Ouwerkerk W; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zannad F; Zwinderman AH; de Borst MH
Int J Cardiol; 2018 Feb; 253():84-90. PubMed ID: 29306478
[TBL] [Abstract][Full Text] [Related]
28. A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF).
Masson R; Ambrosy AP; Kheder K; Fudim M; Clare RM; Coles A; Hernandez AF; Starling RC; Ezekowitz JA; O'Connor CM; Mentz RJ
J Cardiovasc Transl Res; 2020 Aug; 13(4):540-548. PubMed ID: 31933144
[TBL] [Abstract][Full Text] [Related]
29. Development and validation of multivariable models to predict mortality and hospitalization in patients with heart failure.
Voors AA; Ouwerkerk W; Zannad F; van Veldhuisen DJ; Samani NJ; Ponikowski P; Ng LL; Metra M; Ter Maaten JM; Lang CC; Hillege HL; van der Harst P; Filippatos G; Dickstein K; Cleland JG; Anker SD; Zwinderman AH
Eur J Heart Fail; 2017 May; 19(5):627-634. PubMed ID: 28247565
[TBL] [Abstract][Full Text] [Related]
30. The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF Subanalysis.
Bayes-Genis A; Núñez J; Zannad F; Ferreira JP; Anker SD; Cleland JG; Dickstein K; Filippatos G; Lang CC; Ng LL; Ponikowski P; Samani NJ; van Veldhuisen DJ; Zwinderman AH; Metra M; Lupón J; Voors AA
J Am Coll Cardiol; 2017 Oct; 70(17):2128-2136. PubMed ID: 29050560
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of growth differentiation factor-15 in Chinese patients with heart failure: A prospective observational study.
Wang H; Chen Q; Li Y; Jing X; Yang J
Cardiol J; 2018; 25(2):245-253. PubMed ID: 28612904
[TBL] [Abstract][Full Text] [Related]
32. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).
Ambrosy AP; Bhatt AS; Gallup D; Anstrom KJ; Butler J; DeVore AD; Felker GM; Fudim M; Greene SJ; Hernandez AF; Kelly JP; Samsky MD; Mentz RJ
Am J Cardiol; 2017 Jul; 120(1):98-105. PubMed ID: 28479167
[TBL] [Abstract][Full Text] [Related]
33. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
34. Serum level of tumor marker carbohydrate antigen-CA125 in heart failure.
Durak-Nalbantic A; Resic N; Kulic M; Pecar E; Zvizdic F; Dzubur A; Dilic M; Gojak R; Sokolovic S; Hodzic E; Brdjanovic S
Med Arch; 2013; 67(4):241-4. PubMed ID: 24520743
[TBL] [Abstract][Full Text] [Related]
35. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
[TBL] [Abstract][Full Text] [Related]
36. Differences in Clinical Profile and Outcomes of Low Iron Storage vs Defective Iron Utilization in Patients With Heart Failure: Results From the DEFINE-HF and BIOSTAT-CHF Studies.
Grote Beverborg N; van der Wal HH; Klip IT; Anker SD; Cleland J; Dickstein K; van Veldhuisen DJ; Voors AA; van der Meer P
JAMA Cardiol; 2019 Jul; 4(7):696-701. PubMed ID: 31188392
[TBL] [Abstract][Full Text] [Related]
37. Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure.
Docherty KF; McDowell K; Welsh P; Osmanska J; Anand I; de Boer RA; Køber L; Kosiborod MN; Martinez FA; O'Meara E; Ponikowski P; Schou M; Berg DD; Sabatine MS; Morrow DA; Jarolim P; Hammarstedt A; Sjöstrand M; Langkilde AM; Solomon SD; Sattar N; Jhund PS; McMurray JJV
J Am Coll Cardiol; 2023 Jul; 82(2):142-157. PubMed ID: 37407113
[TBL] [Abstract][Full Text] [Related]
38. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?
Núñez J; Núñez E; Consuegra L; Sanchis J; Bodí V; Martínez-Brotons A; Bertomeu-González V; Robles R; Bosch MJ; Fácila L; Darmofal H; Llàcer A
Heart; 2007 Jun; 93(6):716-21. PubMed ID: 17164487
[TBL] [Abstract][Full Text] [Related]
39. Clinical utility of antigen carbohydrate 125 in heart failure.
Núñez J; Miñana G; Núñez E; Chorro FJ; Bodí V; Sanchis J
Heart Fail Rev; 2014 Sep; 19(5):575-84. PubMed ID: 23925386
[TBL] [Abstract][Full Text] [Related]
40. Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure.
Khanam SS; Choi E; Son JW; Lee JW; Youn YJ; Yoon J; Lee SH; Kim JY; Ahn SG; Ahn MS; Kang SM; Baek SH; Jeon ES; Kim JJ; Cho MC; Chae SC; Oh BH; Choi DJ; Yoo BS
PLoS One; 2018; 13(11):e0206380. PubMed ID: 30485284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
